New treatment possibility for some cancer patients

Larotrectinib is approved by NICE as an option for NTRK fusion-positive solid tumours Picture: iStock Essential facts Larotrectinib is one of a new breed of cancer drugs designed to target specific changes in the DNA of cancer cells, rather than where the disease is growing in the body. This means patients, including children, with various cancer types may benefit from its use. It is particularly useful for those patients at an advanced stage of cancer, when other options are limited or have been exhausted.

Choose a Hospital for Cancer Treatment, Learn How

Novel cancer treatment offers new hope when chemo and radiation fail: 'Big change in people's lives

Terminal Cancer Treatment: Richard Scolyer Tests Immune Therapies on Himself - Bloomberg

UK breast cancer patients undergo proton beam therapy in world-first trial on NHS

Hydroxychloroquine combination risky for cancer patients with COVID-19 - study

Frontiers Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches

PRIME® Online Activity - Treatment and Management of Patients With High-Risk or Advanced HR+/HER2- Breast Cancer

For some cancer patients, precision medicine offers hope – and possibility of financial ruin

New treatment possibility for ER+ breast cancer is headed toward clinical trials, News & Stories

More time is more hope

Cancer patients 'at risk' due to treatment delays, doctors say

PSMA-therapy with Actinium-225

Clinical update, Cancer Nursing Practice

Experimental Lung Cancer Treatment: Pros, Cons, Options

A biomarker has been identified in patients with head and neck cancer that will help to avoid unnecessary surgery - Diari digital de la URV